First Human Case of Shamonda Virus Confirmed in France Amid Investigation Into Patient Death
- A patient in France has become the first human known to have contracted the Shamonda virus, dying in Lyon in early October after receiving treatment for a serious...
- The patient contracted the virus in eastern France, where authorities identified the leading hypothesis as an insect bite from the Culicoides midge.
- Prior to its detection in humans, the virus had appeared in European livestock.
A patient in France has become the first human known to have contracted the Shamonda virus, dying in Lyon in early October after receiving treatment for a serious illness, health authorities reported. The European Centre for Disease Prevention and Control and the French agriculture ministry confirmed that the man was severely immunocompromised, leaving investigators working to determine whether the insect-borne bunyavirus directly contributed to his death.
Detection in Lyon and Livestock Exposure in France
The patient contracted the virus in eastern France, where authorities identified the leading hypothesis as an insect bite from the Culicoides midge. The Shamonda virus had been actively circulating among animals in that region during the spring and summer of 2026. The French agriculture ministry classified the case as exceptional, given that the pathogen was previously considered non-transmissible to humans.
Prior to its detection in humans, the virus had appeared in European livestock. The Austrian Agency for Health and Food Safety documented the presence of Shamonda virus genetic material in the brains of horses that succumbed to neurological symptoms in Switzerland and Germany. In farm animals such as cattle, sheep, and goats, the virus typically causes diarrhoea, a lack of appetite, and reduced milk yields, alongside congenital abnormalities and abortions in newborns.
Public Health Risk and Expert Assessment
Public health agencies emphasize that the risk to the wider population remains minimal. Professor Tom Solomon, director of the pandemic institute at the University of Liverpool, explained that transmission to humans is extremely unusual, noting that the virus has circulated in animals for many years without previous human cases. Dr. Ben Brennan from the MRC-University of Glasgow’s centre for virus research added that current data shows no evidence of sustained transmission between humans, advising that most people have no reason to alter their normal activities or take extra precautions.
Ongoing Investigations Into the Lyon Fatal Case
Clinical, laboratory, and epidemiological investigations continue as French authorities coordinate with the World Health Organization and the European Centre for Disease Prevention and Control. While French authorities believe the patient’s neurological complications before death were very likely linked to the infection, investigators have not yet resolved whether the virus caused the fatality or merely infected an already failing immune system. Key questions regarding whether healthy humans can contract asymptomatic infections or how frequently the virus causes severe disease remain unanswered as surveillance efforts proceed.
